×

US FDA approves Roche’s oral treatment for advanced breast cancer

By Thomson Reuters Nov 16, 2026 | 2:46 PM

(Corrects paragraph 1 and headline ​to ‌state that the treatment is ‌for ​advanced ⁠breast cancer, ⁠not early-stage breast cancer)

Nov 16 (Reuters) – ​The US ⁠Food ⁠and Drug ​Administration approved ​Roche’s oral treatment ‌for certain patients with ⁠estrogen receptor-positive, HER2-negative advanced breast ⁠cancer, ‌the ⁠regulator said ​on ‌Monday.

(Reporting ​by Sahil ⁠Pandey in Bengaluru; Editing by Shinjini ​Ganguli)